Status:
COMPLETED
Rosuvastatin and Evolocumab for Coronary Artery Disease
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the retrospective study is to characterize the molecular mechanisms responsible for the effect of statins and evolocumab in patients with stable coronary artery disease. The research team w...
Detailed Description
The researchers will use the previously collected transcriptomic and intravascular imaging data collected from subjects between 8/1/2013-4/14/2015 (statin group) and subjects who participated in YELLO...
Eligibility Criteria
Inclusion
- Subjects with coronary artery disease who underwent cardiac catheterization with or without PCI
- Patients from 8/1/2013-4/14/2015 and YELLOW III with both visits available, baseline and follow-up
Exclusion
- patients from 8/1/2013-4/14/2015 and YELLOW III lost to follow-up
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 28 2022
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT05984953
Start Date
August 1 2013
End Date
October 28 2022
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029